Search For "astrazeneca"
UK regulator receives govt's request to assess Oxford/AstraZeneca
Updated : 2 days, 4 hours ago IST
London [UK], November 27 (ANI/Sputnik): The UK Medicines and Healthcare products Regulatory Agency (MHRA) confirmed on Friday that it has received a request from the government's Department of Health and Social Care to assess the COVID-19 vaccine being developed by the University of Oxford a
Read More
Russian research center suggests use of Sputnik V to boost efficac
Updated : 2 days, 21 hours ago IST
Moscow [Russia], November 27 (ANI/Sputnik): The Russian Gamaleya research institute has suggested UK pharmaceutical company AstraZeneca try to boost the efficacy of its COVID-19 vaccine, combining it with a shot of Russian COVID-19 vaccine Sputnik V.
Read More
PM Modi to visit Serum Institute of India on November 28
Updated : 3 days, 1 hour ago IST
Pune (Maharashtra) [India], November 26 (ANI): Prime Minister Narendra Modi will on Saturday visit Serum Institute of India, which has partnered with AstraZeneca and Oxford University for production of vaccine against COVID-19.
Read More
AstraZeneca's signs MoU with Indian Diabetes Research Society (RSS
Updated : 3 days, 5 hours ago IST
Bangalore (Karnataka) [India], November 26 (ANI/PRNewswire): AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, today signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI).
Read More
Philippines logs 1,392 new COVID-19 cases, plans to buy 2 million
Updated : 3 days, 8 hours ago IST
Manila [The Philipines], November 26 (ANI/Xinhua): The Department of Health (DOH) of the Philippines on Thursday reported 1,392 new confirmed cases of COVID-19 infection, bringing the total number in the country to 424,297.
Read More
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-
Updated : 6 days, 9 hours ago IST
New Delhi [India], November 23 (ANI): With an efficacy of around 90 per cent positive results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil the vaccine has proved to be highly effective in preventing COVID-19, said AstraZeneca on Monday.
Read More
Production of AstraZeneca COVID-19 vaccine begins in Australia
Updated : 2 weeks, 6 days ago IST
Canberra [Australia], November 9 (ANI/Sputnik): The CSL Limited company started production of the University of Oxford/AstraZeneca coronavirus vaccine on Monday, Australian media report.
Read More
AstraZeneca misses target for delivery of COVID-19 vaccine: UK Gov
Updated : 3 weeks, 3 days ago IST
London [UK], November 5 (ANI/Sputnik): The pharmaceutical giant AstraZeneca has missed its target of delivering 30 million doses of its vaccine against COVID-19 to the UK by September, as the producer is predicted to only hand over 4 million doses by the end of the year, Kate Bingham, the he
Read More
AstraZeneca resumes US COVID-19 vaccine trial
Updated : 1 month ago IST
London [UK], October 24 (ANI): The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time).
Read More
Brazil's COVID-19 vaccine volunteer dies, authorities say trial
Updated : 1 month, 1 week ago IST
Brasilia [Brazil], October 22 (ANI): A volunteer in Brazil's clinical trial of COVID-19 vaccine being developed by AstraZeneca and Oxford University has died, the Brazilian health agency Anvisa announced on Wednesday while adding that the trial will continue.
Read More
Trudeau announces vaccine pact as Canada surpasses 150,000 Covid c
Updated : 2 months ago IST
Toronto [Canada], September 26 (ANI/Sputnik): Canadian Prime Minister Justin Trudeau on Friday announced that his government has entered into an agreement with British pharmaceutical giant AstraZeneca to procure 20 million doses of its coronavirus vaccine.
Read More
Serum Institute all set to begin phase 3 trials of Covid-19 vaccin
Updated : 2 months, 1 week ago IST
Pune (Maharashtra) [India], September 19 (ANI): Serum Institute of India (SII) is all set to begin phase three trials of the Covishield Vaccine developed by AstraZeneca and Oxford University at Sassoon General Hospital in Pune, the hospital administration said on Saturday.
Read More